Skip to main content

Advertisement

Log in

Heart rate variability shows different cardiovascular modulation in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype

  • Neurology and Preclinical Neurological Studies - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

Parkinson’s disease (PD) can present with different motor subtypes depending on the predominant symptoms (tremor or rigidity/bradykinesia). Slower disease progression and less cognitive decline are observed in tremor-dominant patients compared to those with akinetic-rigid subtype. Autonomic cardiovascular disorders have been described in parkinsonian patients, although the definite correlations with different subtypes of PD are not clear. In this context, heart rate variability (HRV) analysis represents a non-invasive and established tool in assessing cardiovascular autonomic modulation. We investigate cardiovascular autonomic modulation in PD patients with tremor dominant subtype in comparison to akinetic rigid dominant subtype subjects using HRV analysis. Twenty-eight PD patients (17 with tremor dominant subtype and 11 with akinetic rigid dominant subtype) were enrolled and compared to 17 age and sex-matched healthy controls. HRV was analyzed in time- and frequency-domains. Low-frequency (LF) values were significantly lower in the akinetic rigid dominant subtype than in the tremor dominant group [LF 41.4 ± 13.6 vs 55.5 ± 11.6 (p < 0.007)] indicating that the disease led to a more evident impairment of the baroreflex modulation of the autonomic outflow mediated by both sympathetic and parasympathetic systems in the first class of patients. These findings support the biological relevance of clinical subtypes supporting the idea of a different pathophysiological process between these subtypes. These differences also suggest that different subtypes may also result in different responses to therapy or in the possible development of cardiovascular side effects of dopaminergic drugs in these different populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Cadeddu C, Deidda M, Mercuro G, Tuveri A, Muroni A, Nocco S et al (2010) Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy. Epilepsy Res 92(2–3):145–152

    Article  PubMed  Google Scholar 

  • Camm AJ, Malik M, Bigger JT et al (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing Electrophysiology. Circulation 93:1043–1065

    Article  Google Scholar 

  • Chaudhuri KR, Healy D, Schapira AHV (2006) The non-motor symptoms of Parkinson’s disease. Diagnosis and management. Lancet Neurol 5:235–245

    Article  PubMed  Google Scholar 

  • Eckberg DL (1997) Sympathovagal balance: a critical appraisal. Circulation 96(9):3224–3232

    Article  CAS  PubMed  Google Scholar 

  • Eggers C, Kahraman D, Fink GR, Schmidt M, Timmermann L (2011) Akinetic-rigid and tremor-dominant Parkinson’s disease patients show different patterns of FP-CIT single photon emission computed tomography. Mov Disord 26(3):416–423

    Article  PubMed  Google Scholar 

  • Evans AH, Katzenschlager R, Paviour D, O’Sullivan JD, Appel S, Lawrence AD et al (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405

    Article  PubMed  Google Scholar 

  • Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198

    Article  CAS  PubMed  Google Scholar 

  • Friedrich C, Rudiger H, Schmidt C, Herting B, Prieur S et al (2008) Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes. J Neural Transm 115:1527–1536

    Article  CAS  PubMed  Google Scholar 

  • Goetz CC (2003) The unified Parkinson’s disease rating scale (UPDRS): status and recommendations. Mov Disord 18(7):738–750

    Article  Google Scholar 

  • Goldstein DS (2003) Dysautonomia in Parkinson’s disease: neurocardiological abnormalities. Lancet Neurol 2(11):669–676

    Article  PubMed  Google Scholar 

  • Goldstein DS, Bentho O, Park MY, Sharabi Y (2011) Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol 96(12):1255–1261

    Article  PubMed Central  PubMed  Google Scholar 

  • Hoehn MM, Yahr MD (1967) Parkinsonism: onset. progression and mortality. Neurology 17(5):427–442

    Article  CAS  PubMed  Google Scholar 

  • Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Jankovic J, McDermott M, Carter J, Parkinson Study Group et al (1990) Variable expression of Parkinson’s disease: a baseline analysis of the DATATOP cohort. Neurology 40(10):1529–1534

    Article  CAS  PubMed  Google Scholar 

  • Jellinger KA (1999) Post-mortem studies in Parkinson’s disease. Is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 56:1–29

    Article  CAS  PubMed  Google Scholar 

  • Kay SM, Marple SLJ (1981) Spectrum analysis: a modern perspective. Proc IEEE 69:1380–1419

    Article  Google Scholar 

  • Langston JW (2006) The Parkinson’s complex: parkinsonism is just the tip of the iceberg. Ann Neurol 59:591–596

    Article  PubMed  Google Scholar 

  • Lewis SJG, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005) Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343–348

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lewis MM, Du G, Sen S et al (2011) Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson’s disease. Neuroscience 177:230–239

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Maetzler W, Karam M, Berger MF, Heger T, Maetzler C, Ruediger H, Bronzova J, Lobo PP, Ferreira JJ, Ziemssen T, Berg D (2014) Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson’s disease. J Neural Transm (Epub ahead of print)

  • Mathias CJ (1998) Cardiovascular autonomic dysfunction in parkinsonian patients. Clin Neurosci 5(2):153–166

    CAS  PubMed  Google Scholar 

  • Mitsui J, Saito Y, Momose T, Shimizu J, Arai N, Shibahara J et al (2006) Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease. J Neurol Sci 243(1–2):101–104

    Article  CAS  PubMed  Google Scholar 

  • Oh JY, Kim YS, Choi BH, Sohn EH, Lee AY (2009) Relationship between clinical phenotypes and cognitive impairment in Parkinsons disease. Arch Gerontol Geriatr 49:351–354

    Article  PubMed  Google Scholar 

  • Pagani M, Montano A, Porta A, Malliani A, Abboud FM, Birkett C, Somers CK (1997) Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 95:1441–1448

    Article  CAS  PubMed  Google Scholar 

  • Rossi C, Frosini D, Volterrani D et al (2010) Differences in nigro-striatal impairment in clinical variants of early Parkinson’s disease: evidence from a FP-CIT SPECT study. Eur J Neurol 17(4):626–630

    Article  CAS  PubMed  Google Scholar 

  • Taki J, Yoshita M, Yamada M, Tonami N (2004) Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med 18(6):453–461

    Article  PubMed  Google Scholar 

  • Valappil RA, Black JE, Broderick MJ, Carrillo O, Frenette E, Sullivan SS, Goldman SM, Tanner CM, Langston JW (2010) Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson’s disease. Mov Disord 25(14):2296–2303

    Article  PubMed  Google Scholar 

  • Ziemssen T, Reichmann H (2010) Cardiovascular autonomic dysfunction in Parkinson’s disease. J Neurol Sci 289(1–2):74–80

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Authors gratefully thank Mr. Barry Mark Wheaton for his editorial and linguistic assistance. Dr. Paolo Solla gratefully acknowledges Sardinia Regional Government for the financial support (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007–2013—Axis IV Human Resources, Objective l.3, Line of Activity l.3.1 “Avviso di chiamata per il finanziamento di Assegni di Ricerca”). Dr. Paolo Solla gratefully acknowledges Fondazione Banco di Sardegna for the financial support.

Conflict of interest

The authors declare that they have no conflict of interest. P. Solla has received institutional research funding from the University of Cagliari, received funding from the Fondazione Banco di Sardegna, and received research grant from the Dystonia Europe. Christian Cadeddu reports no disclosures relevant to the manuscript. Antonino Cannas reports no disclosures relevant to the manuscript. Martino Deidda reports no disclosures relevant to the manuscript. Nicola Mura reports no disclosures relevant to the manuscript. Giuseppe Mercuro reports no disclosures relevant to the manuscript. Francesco Marrosu reports no disclosures relevant to the manuscript.

Ethical standard

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian Cadeddu.

Additional information

P. Solla and C. Cadeddu contributed equally to this study.

G. Mercuro and F. Marrosu are senior authors and contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Solla, P., Cadeddu, C., Cannas, A. et al. Heart rate variability shows different cardiovascular modulation in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype. J Neural Transm 122, 1441–1446 (2015). https://doi.org/10.1007/s00702-015-1393-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-015-1393-5

Keywords

Navigation